PI-LAB-2026-0001

Semaglutide — Independent Lab Report

Semaglutide 5mg (lyophilized) · Apex Peptides

Verified
Purity (HPLC) 99.1% Identity confirmed. Purity and content both exceeded label claims.
Laboratory
Vantage Analytical Labs
Test type
Purity + Content
Lot
AX-2604-S5
Purchased
Tested
Published

Findings

Metric Label claim Measured Assessment
Purity (HPLC) ≥ 98% 99.1% Meets claim
Content (mass spec) 5.0 mg 5.1 mg Within 5% of label
Identity (LC-MS) Semaglutide Confirmed Match

Methodology

RP-HPLC purity; LC-MS identity; quantitative amino acid analysis.

The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Vantage Analytical Labs. See our full testing methodology.

Testing notes

Sample purchased anonymously through standard retail checkout. Cold-packed on arrival.

Original laboratory report: PI-LAB-2026-0001-report.pdf (document delivery arrives with the production storage backend)

More Tests — Apex Peptides

BPC-157
Purity 98.9% Verified
Retatrutide
Purity 98.8% Verified
Tirzepatide
Purity 98.8% Verified

More Tests — Semaglutide

Semaglutide Sterling Compound Co.
Purity 96.8% Discrepancy
Semaglutide Research Peptides Co.
Purity 98.9% Verified